What is the SpaceX stock symbol?
That's a question we've been receiving a lot lately, since there's been much news regarding the aerospace company.
What Is the SpaceX Stock Symbol?
Here's what investors need to know about SpaceX today...
ABBV
Abbvie Inc
When Is Snapchat's Earnings Call?
When is Snapchat's earnings call?
It will be on May 10, 2017.
Top Stocks to Watch Today: AMD, ABBV, MGI
The top three stocks to watch today are AMD, ABBV, and MGI.
The likelihood of a June rate hike has decreased after consumer prices fell in March.
Here's what you need to know this morning...
The 5 Best Medical Marijuana Stocks to Watch in 2017
With legalized marijuana sweeping the nation, investors are seeking out the best medical marijuana stocks to watch in 2017. The new reality is that Americans now overwhelmingly approve of marijuana legalization. The latest Gallup poll from 2016 showed 60% of Americans are in favor of legalizing marijuana. Here are some numbers showing how much the marijuana industry is […]
Here's everything you need to know about the five medical marijuana stocks on our radar this year...
Yext IPO and Stock: Everything You Need to Know About the $525 Million Company
Patient investors have been waiting for the Yext IPO date for years.
Finally, the tech company filed for an IPO on March 13, 2017.
Dow Jones News: Dow Drops After President Trump Calls for Budget Cuts in Healthcare Spending
In Dow Jones news today, the Dow was down after President Donald Trump proposed new budget cuts in the healthcare industry.
Investors are also weighing the decision by the Federal Reserve to raise interest rates.
Timing the Market Now Can Double Your Money
While many are understandably skeptical, timing the market now can help you boost profits in 2017.
The high prices and high volatility in the markets today can leave you questioning if a stock is priced too high.
3 Medical Marijuana Stocks to Watch
Medical marijuana stocks offer investors an opportunity to gain exposure to $10.7 billion in sales growth by 2020.
Celebrate This High-Profit Milestone with Some More Triple-Digit Gains
This was the very first stock we recommended on the very first day Private Briefing was published – Aug. 11, 2011.
On that day, you could've owned it for less than nine bucks a share – $8.60.
That's a distant memory.
We've re-recommended these shares more than a dozen times since then, so successive "classes" of our readers can participate in these gains.
And sure enough, this stock hit an all-time high at midday yesterday… up a whopping 717% from that first day we wrote about it.
The Way to Profit from the Biotech Story No One Is Talking About
The biotech sector has rebounded from its sharp sell-off, up 16% since June 27.
And as the comeback continues, this is the best investment to partake in the gains...